CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial. Chimney technique in a TAVR-in-TAVR procedure with high risk of left main artery ostium occlusion Stage-dependent differential effects of interleukin-1 isoforms on experimental atherosclerosis Prognostic implications of baseline 6‐min walk test performance in intermediate risk patients undergoing transcatheter aortic valve replacement Long-term outcome of prosthesis-patient mismatch after transcatheter aortic valve replacement 2021 ACC/AHA Key Data Elements and Definitions for Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Heart Failure) Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial Considerations for Optimal Device Selection in Transcatheter Aortic Valve Replacement: A Review Association of Reduced Apical Untwisting With Incident HF in Asymptomatic Patients With HF Risk Factors
|<<... 100 101 102 103 104 105 106 ...>>|

Clinical Trial2011 Feb 22;57(8):914-20.

JOURNAL：J Am Coll Cardiol. Article Link

A randomized clinical study comparing double kissing crush with provisional stenting for treatment of coronary bifurcation lesions: results from the DKCRUSH-II (Double Kissing Crush versus Provisional Stenting Technique for Treatment of Coronary Bifurcation Lesions) trial

Chen SL, Santoso T, Zhang JJ et al. Keywords: DK Crush technique; provisional stenting; MACE

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top